• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar for Week of Oct. 1-5, 2007

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Andrew von Eschenbach, Commissioner, Food and Drugs10/2/07Rockville, MDRandy Lutter, Larry Bachorik, Laurie Lenkel, Julie Zawisa, Les Weinstein, Virginia Behr, Howard Balick, Beth ClarkeJoe Panetta, Ben Avery, Michele Yelemene, Michael Mentesana (BIOCom)BIOCom’s 2006 survey of pharmaceutical, biotechnology, and medical device companies and their working relationship with FDA
 
Andrew von Eschenbach, Commissioner, Food and Drugs10/4/07Rockville, MDPatricia Keegan, Seth Ray, Jeffrey Senger, Richard Pazdur, Susan Winckler, Patricia Delaney, Yolanda Jenkins  Baker Donelson Bearnan, Nancy Johnson, Lance Leggitt (Caldwell & Berkowitz, PC), Ted Okon (Community Oncology Alliance (COA), Lee  Schwartzberg (The West Clinic), Arthur Staddon (University of Pennsylvania Health System)FDA panel recommendations related to anemia drugs
 
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer10/1/07 through 10/5/07N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs10/1/07 through 10/5/07N/AN/AN/ANo significant meetings
Randall Lutter, Deputy Commissioner for Policy10/4/07TeleconferenceN/AMichael Lazarus, Bob Wolfe, Ron Keurbitz (Fresenius Medical Care North America)Renal Data Analyses
Randall Lutter, Deputy Commissioner for Policy10/4/07Rockville, MDIrene ChanIan Ascough, William Sargent (Dept. for Business, Enterprise and Regulatory Reform)Regulatory reform issues for the UK government
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research10/1/07Cleveland, OHN/AEllen Sigal, Marlene Malek (Friends of Cancer Research), John Niederhuber (NIH)Critical Path Initiative as it relates to cancer research
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research10/5/07Washington, DCRobert Temple, Robert O'Neill, Ann StatenEllen Stoval (National Coalition for Cancer Survivorship)Workshop on improving cancer clinical trials
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs10/1/07 through 10/5/07N/AN/AN/ANo significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research10/5/07Geneva, SwitzerlandN/AWHOPandemic influenza vaccines
Daniel Schultz, Director, Center for Devices and Radiological Health10/2/07Rockville, MDTom Gross, David Buckles, Lily NgSusan Alpert, Scott Ward (Metronic)Device issues
Daniel Schultz, Director, Center for Devices and Radiological Health10/3-4/07Washington, DCCommittee membersConferenceGlobal Harmonization Task Force Conference
Daniel Schultz, Director, Center for Devices and Radiological Health10/5/07Rockville, MDN/ARobert Jarvik (Jarvik Heart)Device issues
Robert Brackett, Director, Center for Food Safety and Applied Nutrition10/1/07 through 10/5/07N/AN/AN/ANo significant meetings
Stephen Sundlof, Director, Center for Veterinary Medicine10/3/07TeleconferenceMerton Smith, Steve Vaughn, Dan McChesneyIan Alexander, Louis Boulay, Manisha Mehrotra, Michelle Nicholson, Rajinder Sharma (Canadian Veterinary Drugs Directorate Staff)Bilateral meeting with the Canadian Veterinary Drugs Directorate to discuss mutual veterinary drug issues
William Slikker, Director, National Center for Toxicological Research (NCTR)10/1/07 through 10/5/07N/AN/AN/ANo significant meetings
Jeffrey Senger, Acting Chief Counsel10/1/07 through 10/5/07N/AN/AN/ANo significant meetings